难治性免疫性血小板减少症(ITP)的发病机制:概述
部分原发性或特发性免疫性血小板减少症(ITP)患者对常规一线和二线治疗无反应或失去反应,被视为难治性疾病(rITP),面临出血和强化治疗并发症风险增加。难治状态的判定标准在不同研究间存在差异,rITP是单纯更严重的ITP还是存在特定致病通路尚不明确。本文综述了可能与rITP相关的生物学特征,包括遗传与表观遗传风险因素、T细胞与细胞因子网络失调、抗体亲和力与特异性、补体激活、血小板生成受损及血小板存活与清除改变,并指出需采用新型临床可用方法开展纵向研究以识别和监测致病性T细胞、血小板抗体及其他难治性疾病发展线索。
要点
- 难治性ITP(rITP)定义标准不一,增加出血和强化治疗并发症风险。
- rITP可能涉及遗传、T细胞、抗体、补体及血小板生成与清除等多环节异常。
- 需纵向研究用新型临床方法识别和监测致病性T细胞和血小板抗体等线索。
核心结论
- rITP的判定标准在不同研究间存在差异,rITP是单纯更严重的ITP还是存在特定致病通路尚不明确。
- 综述提示多种生物学特征可能与rITP相关,需纵向研究用新型临床可用方法识别和监测致病性T细胞、血小板抗体及其他线索。
研究设计与样本
- 本文为综述,汇总可能与难治性ITP相关的潜在生物学特征。
主要发现
- 可能与rITP相关的生物学特征包括遗传与表观遗传风险因素、T细胞与细胞因子网络失调、抗体亲和力与特异性、补体激活、血小板生成受损及血小板存活与清除改变。
局限性
- 原文指出难治状态的判定标准在不同研究间存在差异,使研究和临床调查复杂化。
- 原文指出rITP是单纯更严重的ITP还是存在特定致病通路尚不明确。
- 原文指出rITP能否基于这些差异被确立或预测尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A subset of individuals with 'primary' or 'idiopathic' immune thrombocytopenia (ITP) who fail to respond to conventional first- and second-line agents or who lose responsiveness are considered to have 'refractory' disease (rITP), placing them at increased risk of bleeding and complications of intensive treatment. However, the criteria used to define the refractory state vary among studies, which complicates research and clinical investigation. Moreover, it is unclear whether rITP is simply 'more severe' ITP, or if there are specific pathogenic pathways that are more likely to result in refractory disease, and whether the presence or development of rITP can be established or anticipated based on these differences. This paper reviews potential biological features that may be associated with rITP, including genetic and epigenetic risk factors, dysregulation of T cells and cytokine networks, antibody affinity and specificity, activation of complement, impaired platelet production and alterations in platelet viability and clearance. These findings indicate the need for longitudinal studies using novel clinically available methodologies to identify and monitor pathogenic T cells, platelet antibodies and other clues to the development of refractory disease.
引用
- Cines DB. Pathogenesis of refractory ITP: Overview. Br J Haematol. 2023. PMID: 37735546. doi:10.1111/bjh.19083
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。